Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Home on the range where the buffalo roam -- Ignore unavailable to you. Want to Upgrade?

To: Boplicity who wrote (2411)	6/13/2000 7:53:00 AM
From: Wyätt Gwyön	Read Replies (1) \| Respond to of 13572

The rumor that SDLI is being bought about by GLW is just that a rumor I agree, but it also kind of makes sense. I guess we will find out in a few minutes how the market takes it. I am glad SDL made its recent run on its own fundamentals. I attended the SDL annual meeting and the CEO was asked about whether they could be an acquisition target. He did not rule out the possibility, and GLW's photonics group could be a great partner.

To: Boplicity who wrote (2411)	6/13/2000 8:29:00 AM
From: r.edwards	Read Replies (1) \| Respond to of 13572

re;CRA and GERN,Celera & Geron, by: JDBarron 6/13/00 7:16 am Msg: 20428 of 20434 Each time a cell divides (except for stem cells and germ line cells) it's telomeres (caps on the ends of chromosomes) lose a piece at the end. When the get short enough the cell dies. This is known as the "Hayflick limit": a cell can go thru a limited number of divisions. When dolly was cloned the process did not add any length to the teolmeres so dolly had the same remaining life expectancy as her "mother". The process used in cloning the calves unexpectedly resulted in the telomeres being restored to full length, hence longer life expectancy. A cosmetic skin treatment in the works with telomerease (an enzyme that lengthens telomeres) promises to rejuvinate skin (but nothing else). We have stem cells. It is quite possible that Geron's work may eventually teach us how to significantly extend life by removing our "Hayflick limit", using rejuvinated stem cells to repair aging organs and other such measures. (THIS is one reason why Geron has such a bullish and faithful following!) The skin treatment promises to not be merely "cosmetic" because it might REALLY rejuvinate the skin, not just remove wrinkles or have purely cosmetic effects. And there are indications that we may be able to accomplish such things with other organs as well. A lot of this work has been kept "low profile" for many years because of MISconceptions that life extension would lead to higher levels of infirmity and damage society. Quite the opposite! Live extension technologies offer the promise of REDUCING the period of infirmity at the end of life and increasing the proportion of productive members of society. Recently this issue has begun to enter mainstream thought (now that there is enough hard scientific evidence to show that the potential is real). --------------------------------------------------------------------------------